Niederer Kraft Frey (NKF) advised former Swiss national football player and entrepreneur David Degen on the acquisition of a majority of the shares in FC Basel Holding from Bernhard Burgener. FC Basel Holding owns 75 percent
Tags :NKF
Walder Wyss acted as legal counsel to Montana Aerospace, in its initial public offering (IPO) at the SIX Swiss Exchange. This IPO has been one of the first to take place under the new Swiss
Niederer Kraft Frey (NKF) advised the equity investment company Invision on the acquisition of a majority stake in SkySale Schweiz, advised by Walder Wyss. NKF acted with a team led by Corporate/M&A
Crédit Agricole next bank (Suisse) successfully completed its second issuance under its Swiss Covered Bond Programme, issuing CHF 200 million Series 2021-1 0.125 per cent. Fixed-Rate Covered Bonds due April 2031 (with extended maturity date April 2032). The
The NKF team was led by Capital Markets partner Daniel Bono (pictured), working with senior associate Giulia Ghezzi (Capital Markets), partner Markus Kronauer and associate Vanessa Witschi (both Tax).
Niederer Kraft Frey has announced the new executive committee, comprising the following five partners: Patrik Peyer as Managing Partner, Philipp Haas as Head of Marketing and Business Development, Catherine Grun Meyer as Head of Finance,
The NKF team was led by M&A/Finance partner Adrian Koller, working with partner Till Spillmann, senior associate Andrea Giger, junior associate Selim Lötscher (all M&A/Finance) as well as partner Markus
The NKF team was led by M&A/Finance partners Till Spillmann (pictured) and Adrian Koller, working with junior associates Selim Lötscher and Reto Seiler (both M&A/Finance) as well as partner Markus
NKF acted as legal advisor to the Franke Group in this transaction. The NKF team was led by M&A partner Till Spillmann (pictured right). Bär & Karrer advises funds advised by Equistone on the
The NKF team was led by Corporate/M&A partner Patrik Peyer (pictured), working with associate Corinne Russi, junior associates Tanja Lutz, Thomas van Gammeren (all Corporate/M&A), counsel Janine Reudt-Demont (Life Science/Technology),
